APA (7th ed.) Citation

Matsuda, A., Masuzawa, R., Takahashi, K., Takano, K., & Endo, T. (2025). MEK inhibitors and DA‐Raf, a dominant‐negative antagonist of the Ras–ERK pathway, prevent the migration and invasion of KRAS‐mutant cancer cells. Cytoskeleton, 82(1-2), 32-44. https://doi.org/10.1002/cm.21881

Chicago Style (17th ed.) Citation

Matsuda, Aoi, Ryuichi Masuzawa, Kazuya Takahashi, Kazunori Takano, and Takeshi Endo. "MEK Inhibitors and DA‐Raf, a Dominant‐negative Antagonist of the Ras–ERK Pathway, Prevent the Migration and Invasion of KRAS‐mutant Cancer Cells." Cytoskeleton 82, no. 1-2 (2025): 32-44. https://doi.org/10.1002/cm.21881.

MLA (9th ed.) Citation

Matsuda, Aoi, et al. "MEK Inhibitors and DA‐Raf, a Dominant‐negative Antagonist of the Ras–ERK Pathway, Prevent the Migration and Invasion of KRAS‐mutant Cancer Cells." Cytoskeleton, vol. 82, no. 1-2, 2025, pp. 32-44, https://doi.org/10.1002/cm.21881.